BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 119429
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119429
Table 1 Baseline demographic and clinical characteristics stratified by glycated hemoglobin categories, n (%)/median (interquartile range)
Variable
Total (n = 171)
Normoglycemia (n = 56)
Prediabetes (n = 57)
Diabetes (n = 58)
P value
Age (years)67 (59-75)66 (58-74)67 (60-76)68 (61-77)0.497
Male sex118 (69.0)40 (71.4)39 (68.4)39 (67.2)0.88
Body mass index27.5 (25.1-30.3)27.3 (25.0-30.1)27.6 (25.2-30.4)27.7 (25.3-30.6)0.971
Arterial hypertension132 (77.2)41 (73.2)43 (75.4)48 (82.8)0.34
Admission glucose (mmol/L)7.6 (6.4-9.1)6.7 (6.1-7.5)7.4 (6.5-8.4)9.3 (8.1-11.1)< 0.001
HbA1c (%)6.2 (5.7-7.1)5.5 (5.3-5.7)6.0 (5.8-6.2)7.7 (7.1-8.5)< 0.001
MACE at 3 months88 (51.5)27 (48.2)30 (52.6)31 (53.4)0.674
All-cause mortality at 3 months25 (14.6)7 (12.5)8 (14.0)10 (17.2)0.168


Write to the Help Desk